These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 23866760)

  • 1. Can informal social distancing interventions minimize demand for antiviral treatment during a severe pandemic?
    Greer AL
    BMC Public Health; 2013 Jul; 13():669. PubMed ID: 23866760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination strategies for future influenza pandemics: a severity-based cost effectiveness analysis.
    Kelso JK; Halder N; Milne GJ
    BMC Infect Dis; 2013 Feb; 13():81. PubMed ID: 23398722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using a Dynamic Model to Consider Optimal Antiviral Stockpile Size in the Face of Pandemic Influenza Uncertainty.
    Greer AL; Schanzer D
    PLoS One; 2013; 8(6):e67253. PubMed ID: 23805303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A model-based economic analysis of pre-pandemic influenza vaccination cost-effectiveness.
    Halder N; Kelso JK; Milne GJ
    BMC Infect Dis; 2014 May; 14():266. PubMed ID: 24884470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the effectiveness of interventions used during the 2009 A/H1N1 influenza pandemic.
    Halder N; Kelso JK; Milne GJ
    BMC Public Health; 2010 Mar; 10():168. PubMed ID: 20346187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing tactics for use of the U.S. antiviral strategic national stockpile for pandemic influenza.
    Dimitrov NB; Goll S; Hupert N; Pourbohloul B; Meyers LA
    PLoS One; 2011 Jan; 6(1):e16094. PubMed ID: 21283514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimated impact of aggressive empirical antiviral treatment in containing an outbreak of pandemic influenza H1N1 in an isolated First Nations community.
    Xiao Y; Patel Z; Fiddler A; Yuan L; Delvin ME; Fisman DN
    Influenza Other Respir Viruses; 2013 Nov; 7(6):1409-15. PubMed ID: 23879801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Likely effectiveness of pharmaceutical and non-pharmaceutical interventions for mitigating influenza virus transmission in Mongolia.
    Bolton KJ; McCaw JM; Moss R; Morris RS; Wang S; Burma A; Darma B; Narangerel D; Nymadawa P; McVernon J
    Bull World Health Organ; 2012 Apr; 90(4):264-71. PubMed ID: 22511822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simulation suggests that rapid activation of social distancing can arrest epidemic development due to a novel strain of influenza.
    Kelso JK; Milne GJ; Kelly H
    BMC Public Health; 2009 Apr; 9():117. PubMed ID: 19400970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of optimal antiviral stockpile for a novel influenza pandemic.
    Kim S; Bin Seo Y; Lee J; Kim YS; Jung E
    J Infect Public Health; 2022 Jul; 15(7):720-725. PubMed ID: 35667304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scenarios of diffusion and control of an influenza pandemic in Italy.
    Rizzo C; Lunelli A; Pugliese A; Bella A; Manfredi P; Tomba GS; Iannelli M; Ciofi degli Atti ML
    Epidemiol Infect; 2008 Dec; 136(12):1650-7. PubMed ID: 18272019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of antiviral drugs in containing pandemic influenza. Contribution of recent modelling exercises synthesis prepared by the InVS/Inserm "epidemiology" group - November 2005].
    Lévy-Bruhl D
    Med Mal Infect; 2006 Sep; 36(9):449-53. PubMed ID: 17027218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitigation strategies for pandemic influenza A: balancing conflicting policy objectives.
    Hollingsworth TD; Klinkenberg D; Heesterbeek H; Anderson RM
    PLoS Comput Biol; 2011 Feb; 7(2):e1001076. PubMed ID: 21347316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal strategies of social distancing and vaccination against seasonal influenza.
    Shim E
    Math Biosci Eng; 2013; 10(5-6):1615-34. PubMed ID: 24245639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are we prepared for the next influenza pandemic? Lessons from modelling different preparedness policies against four pandemic scenarios.
    Panovska-Griffiths J; Grieco L; van Leeuwen E; Baguelin M; Pebody R; Utley M
    J Theor Biol; 2019 Nov; 481():223-232. PubMed ID: 31059716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost effectiveness of pandemic influenza interventions: a pandemic severity based analysis.
    Milne GJ; Halder N; Kelso JK
    PLoS One; 2013; 8(4):e61504. PubMed ID: 23585906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling strategic use of the national antiviral stockpile during the CONTAIN and SUSTAIN phases of an Australian pandemic influenza response.
    McVernon J; McCaw JM; Nolan TM
    Aust N Z J Public Health; 2010 Apr; 34(2):113-9. PubMed ID: 23331352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-prioritized use of antivirals during an influenza pandemic.
    Merler S; Ajelli M; Rizzo C
    BMC Infect Dis; 2009 Jul; 9():117. PubMed ID: 19638194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines and antiviral drugs in pandemic preparedness.
    Monto AS
    Emerg Infect Dis; 2006 Jan; 12(1):55-60. PubMed ID: 16494718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of case diagnosis coverage and diagnosis delays on the effectiveness of antiviral strategies in mitigating pandemic influenza A/H1N1 2009.
    Kelso JK; Halder N; Milne GJ
    PLoS One; 2010 Nov; 5(11):e13797. PubMed ID: 21072188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.